Clinical Trial Update: Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study investigating a cell injection therapy for relapsed or refractory CD7-positive hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Cell Injection therapy (CD7-targeted cell therapy)

Snippet

Sponsor: MEI HENG | Conditions: Neoplasms, Hematologic Neoplasms | EARLY_Phase 1 | Status: COMPLETED